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Generating a balanced network of inhibitory and
excitatory neurons during development requires pre-
cise transcriptional control. In the dorsal spinal cord,
Ptf1a, a basic helix-loop-helix (bHLH) transcription
activator, maintains this delicate balance by inducing
homeodomain (HD) transcription factors such as
Pax2 to specify the inhibitory lineagewhile suppress-
ing HD factors such as Tlx1/3 that specify the excit-
atory lineage. We uncover the mechanism by which
Ptf1a represses excitatory cell fate in the inhibitory
lineage. We identify Prdm13 as a direct target of
Ptf1a and reveal that Prdm13 actively represses
excitatory cell fate by binding to regulatory se-
quences near the Tlx1 and Tlx3 genes to silence their
expression. Prdm13 acts through multiple mecha-
nisms, including interactions with the bHLH factor
Ascl1, to repress Ascl1 activation of Tlx3. Thus,
Prdm13 is a key component of a highly coordinated
transcriptional network that determines the balance
of inhibitory versus excitatory neurons in the dorsal
spinal cord.
INTRODUCTION
The central nervous system (CNS) is composed of a balanced
number of excitatory and inhibitory neurons that are intercon-
nected to form neuronal networks essential for information pro-
cessing. In the dorsal spinal cord, which provides the first level
of central somatosensory processing, this excitatory/inhibitory
balance is required to integrate sensory information, including
pain, touch, and proprioception coming into the spinal cord
from dorsal root ganglia, before it is relayed to supraspinal
brain regions or locally for reflex responses (Liu and Ma, 2011;
Ross, 2011). Disruption in this balance can lead to sensory
disorders such as hyperalgesia and allodynia (Fitzgerald, 2005;
Tavares and Lima, 2007). Given the importance of the dorsal
horn neurons in processing all somatosensory modalities,
understanding how these neurons are specified during embryo-182 Developmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier Igenesis to generate the correct composition of neurons is
critical. Here, we identify a key component of the transcriptional
machinery that controls how neurons in the somatosensory cir-
cuit are generated and how regulated specification of these
neurons leads to a correct excitatory/inhibitory balance during
development.
Excitatory and inhibitory neurons in the spinal cord arise from
progenitor populations within the ventricular zone of the dorsal
neural tube (Gross et al., 2002; Mu¨ller et al., 2002). These pro-
genitors are competent to give rise to neurons in either class
depending on the basic helix-loop-helix (bHLH) transcription fac-
tors that are expressed (Helms and Johnson, 2003; Zhuang and
Sockanathan, 2006). For example, ectopic expression of the
bHLH factors Ascl1 (previously Mash1) or Atoh1 (previously
Math1) result in an increase of excitatory neurons at the expense
of neighboring neuronal subtypes (Gowan et al., 2001; Helms
et al., 2005). On the other hand, the bHLH factor Ptf1a is required
for the generation of local circuit inhibitory neurons, and in its
absence excess local circuit excitatory neurons form (Glasgow
et al., 2005).
These functions for the bHLH factors in neuronal subtype
specification highlight a fundamental question in generating
neuronal diversity. A transcription factor with the ability to redi-
rect the fate of a cell requires two activities: it must activate line-
age specific gene expression, and it must repress expression of
genes in the alternate lineage. The current understanding of the
transcriptional network that controls the excitatory/inhibitory
balance in the dorsal horn of the spinal cord has Ptf1a and
Ascl1 acting upstream of homeodomain (HD) factors such as
Pax2 and Lbx1 to specify GABAergic (inhibitory) lineages,
whereas Ascl1 alone acts upstream of Tlx1 and Tlx3 to specify
glutamatergic (excitatory) lineages (Batista and Lewis, 2008;
Bro¨hl et al., 2008; Cheng et al., 2004, 2005; Glasgow et al.,
2005; Helms et al., 2005; Mizuguchi et al., 2006; Wildner et al.,
2006). Because Ascl1 and Ptf1a are transcriptional activators
(Beres et al., 2006; Nakada et al., 2004), the simple model has
Ascl1 directly activating glutamatergic lineage genes and Ptf1a
directly activating GABAergic lineage genes. However, because
both Ascl1 and Ptf1a are expressed in progenitors to the
GABAergic lineages, how the glutamatergic genetic program
in this lineage is suppressed remains unclear (Beres et al.,
2006; Hori et al., 2008; Krapp et al., 1996, 1998; Masui et al.,
2008). Here, we identify a PRDM class transcription repressor,nc.
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can suppress genes in the glutamatergic lineage in the dorsal
spinal cord.
The PRDM family of transcription factors is defined by a PR
domain and a variable number of zinc-finger domains (for review,
see Fog et al., 2012; Fumasoni et al., 2007; Hohenauer and
Moore, 2012). The PR domain has 20%–30% identity to the
SET domain that is found in a class of histonemethyltransferases
(HMTs), which function to silence transcription. Some PRDM
members exhibit intrinsic HMT activity, such as Prdm2, 8, and
9, whereas most PRDM members lack this enzymatic activity.
However, PRDM factors can recruit other histone-modifying
enzymes to mediate their transcriptional activity. Some PRDM
factors have been shown to be essential for regulating cell-fate
decisions. For example, Prdm16 specifies brown fat fate, while
suppressing white fat or muscle (Kajimura et al., 2010; Seale
et al., 2008). In the nervous system, Prdm1 specifies photore-
ceptor over bipolar neuron fate (Brzezinski et al., 2010; Katoh
et al., 2010). Recently, it was reported that Prdm8 regulates cad-
herin-11 to ensure correct targeting of neurons in the cortex
(Ross et al., 2012) and that Prdm14 regulates Isl1 to ensure cor-
rect axon growth of motoneurons in zebrafish (Liu et al., 2012).
Despite the emergence of PRDM family members as impor-
tant regulators of neural development, to date very little is known
about their roles in cell-fate specification and differentiation in
the CNS. In this study, we identify Prdm13 as a critical compo-
nent of the transcription network that regulates neuronal diver-
sity and the excitatory/inhibitory balance in the dorsal spinal
cord. In particular, we show that Prdm13 phenocopies that of
Ptf1a in the CNS, where Prdm13 is both necessary and sufficient
to promote Pax2+/GABAergic over Tlx1/3+/glutamatergic neu-
ronal fate. Moreover, we present evidence that Prdm13 directly
represses the glutamateric-neuron-specifier genes Tlx1 and
Tlx3, thereby indirectly resulting in a derepression of the
Pax2+/GABAergic lineage (Cheng et al., 2004, 2005). Finally,
we reveal a mechanism suggesting Prdm13 physically interacts
with Ascl1 to silence Ascl1’s transcriptional activity on the Tlx3
gene. Together, our findings put Prdm13 at the center of the
bHLH and HD transcription factor cascade that governs cell-
fate decisions, and its function is central to the generation of a
balanced circuitry of excitatory and inhibitory neurons required
for somatosensory information processing.
RESULTS
Ptf1a Activity Is Dominant over Ascl1 in Specification of
Dorsal Spinal Cord Neurons
During development of the dorsal spinal cord, progenitor popu-
lations are defined by expression of bHLH transcription factors,
including Ascl1 and Ptf1a (see diagram Figure 1A) (Glasgow
et al., 2005; Helms et al., 2005). At embryonic day 10.5 (E10.5),
Ascl1 is present in progenitors to interneurons dI3, dI4, and
dI5, whereas Ptf1a is coexpressed with Ascl1 in progenitors to
dI4. Functionally, overexpression of Ascl1 in ovo in chick neural
tube induces expression of the homeodomain (HD) factors
Tlx1/3, Isl1, and Lmx1b (dI3 and dI5) at the expense of Pax2
(dI4) (Figures 1B0, 1B00, 1E, and 1F) (Helms et al., 2005; Mizuguchi
et al., 2006; Wildner et al., 2006). In contrast, overexpression of
Ptf1a represses these factors and instead induces Pax2 andDeveLhx1/5 (Figures 1C0, 1C00, 1E, and 1F) (Glasgow et al., 2005). In
addition to the regulation of these HD factors by Ascl1 and
Ptf1a, crosstalk between the HD factors also occurs because
Tlx1/3 repress the ability of Lbx1 to induce Pax2 (Cheng et al.,
2005) (see diagram Figure 1A). Indeed, ectopic expression of
Lbx1 in the chick neural tube induces Pax2, but only in regions
outside of Tlx1/3 expression (Figure S1B00 available online). The
output from this regulatory network is the specification of either
an excitatory (vGlut2+) or inhibitory (Gad1+) neuronal phenotype
(Cheng et al., 2004, 2005; Glasgow et al., 2005; Gross et al.,
2002; Mu¨ller et al., 2002).
Because progenitors to dI4 express both Ascl1 and Ptf1a,
somemechanismmust exist to repress Ascl1 specification activ-
ities when Ptf1a is present. Ptf1a appears sufficient to repress
Ascl1 activity because ectopic expression of Ptf1a represses
Tlx1 and Tlx3 (Figure 1C0). To test this further, we drove ectopic
expression of Ascl1 and Ptf1a simultaneously in the chick neural
tube. In this paradigm, Ptf1a was dominant over Ascl1, inhibiting
both ectopic and endogenous Tlx1/3 expression, while con-
tinuing to activate Pax2 (Figures 1D0–1F). Given that Ptf1a acts
as a transcriptional activator (Beres et al., 2006), we hypothe-
sized that Ptf1a induces a transcriptional repressor as one of
its downstream targets, and this repressor functions to mediate
the suppression of glutamatergic lineage genes.
Prdm13 Is a Direct Downstream Target of Ptf1a
In order to better understand the transcriptional network that
controls the specification of inhibitory and excitatory neuronal
subtypes in the dorsal spinal cord, we identified direct down-
stream targets of Ptf1a. Targets were defined by intersecting
gene lists identified via Ptf1a chromatin immunoprecipitation
sequencing (ChIP-seq) with genes identified as being Ptf1a-
dependent using expression profiling of Ptf1a mutant neural
tubes compared to heterozygote or wild-type tissues. For
ChIP-seq experiments localizing Ptf1a to chromatin in vivo, chro-
matin from mouse E12.5 neural tube was immunoprecipitated
with antibodies to Ptf1a. Tissue from the telencephalon of the
same embryos was used as a negative neural control as no
Ptf1a was present in this tissue. High-throughput sequencing
of these samples, followed by peak detection revealed Ptf1a
localized to thousands of sites within the genome (D.M.M.,
M.D.B., and J.E.J., unpublished data). For identifying genes
whose expression is Ptf1a-dependent, we performed RNA
sequencing (RNA-seq) from Ptf1a lineage cells sorted from neu-
ral tubes of Ptf1a mutants and heterozygotes at E11.5. These
analyses revealed Prdm13, a member of the PRDM class of pro-
teins, whose expression decreased 4.5-fold in the Ptf1amutant,
as a particularly interesting target (Figure 2A). Given the impor-
tance of the PRDM family of factors to cell-fate decisions in other
tissues (for review, see Fog et al., 2012; Hohenauer and Moore,
2012) and the lack of functional data for Prdm13, we chose to
study this factor to determine its function in neuronal subtype
specification in the dorsal neural tube.
ChIP-seq for Ptf1a identified seven binding regions surround-
ing the Prdm13 gene (Figure 2A). Ptf1a is a component of a
trimeric transcription complex (PTF1) that also includes an
E-protein and Rbpj and binds a DNA motif containing an E-box
and a TC-box with constrained spacing requirements (Beres
et al., 2006; Henke et al., 2009; Hori et al., 2008; Masui et al.,lopmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier Inc. 183
Figure 1. Opposing Activities of Ascl1 and Ptf1a on Neuronal Subtype Specification
(A) Diagram showing the pattern and interacting network of bHLH and LIM-HD transcription factors in the dorsal spinal neural tube.
(B–F) Stage HH12-13 chick embryos were electroporated with expression vectors for Ptf1a and/or Ascl1 and harvested at HH24-25. Transverse sections are
shownwith the electroporated side on the right. Ascl1 (B and D, blue) and Ptf1a (C andD, red) antibodies detect the ectopically expressed proteins. Dashed box in
(B) is the region of the neural tube shown in (B0)–(D00). Dashed vertical line indicates the ventricle. (B0–F) Dorsal neural tube sections show the dI3 and dI5 neuronal
populations marked by Tlx1/3 antibody (B0–D0) or dI4 marked by Pax2 (B00–D00). (E and F) The ratio of Tlx1/3+ or Pax2+ neurons on the electroporated side versus
the control side showing that overexpression of Ascl1 causes a dramatic increase in Tlx1/3+ and decrease in Pax2+ neurons, whereas Ptf1a, or Ascl1 plus Ptf1a,
causes the opposite. Note that ectopic Pax2+ cells (white arrowheads) are found in the dI5 domain not normally expressing Pax2 (yellow arrowhead). Error bars
are reported as SEM. p values < 0.001 between sample and control (*) or between samples (#). NS, not significant.
Figure S1 shows Lbx1 also induces Pax2 (associated with A).
Developmental Cell
Prdm13 Regulates Neuronal Subtype Specification2007). Of the seven regions surrounding the Prdm13 gene bound
by Ptf1a, five contain consensus PTF1 binding motifs (Figure 2B,
underlined sequence). To determine if these Ptf1a-bound re-
gions are occupied by the PTF1 complex, we performed ChIP-
seq on neural tube tissue with antibodies to Rbpj (D.M.M.,
M.D.B., and J.E.J., unpublished data). Examination of the
Prdm13 locus confirmed that Rbpj colocalizes with Ptf1a in
those regions that contain a consensus PTF1 motif (Figure 2A).
All five of the PTF1 sites are conserved across mammalian184 Developmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier Ispecies, and four of them are conserved to zebrafish (Figures
2A and 2B, asterisks).
To verify that Prdm13 is a direct target of Ptf1a, we examined
the Prdm13 expression pattern relative to Ptf1a and in response
to increased or decreased levels of Ptf1a. In the chick, Prdm13 is
expressed in the ventricular zone in the dorsal neural tube (Fig-
ure 2D, control side), and ectopic expression of Ptf1a via in
ovo electroporation resulted in a dramatic increase in endoge-
nous cPrdm13 mRNA levels (Figures 2C and 2D). In mousenc.
Figure 2. Prdm13 Is a Direct Downstream Target of Ptf1a
(A) The mouse genomic region surrounding Prdm13 showing ChIP-seq for Ptf1a from E12.5 neural tube (blue) and telencephalon (green) or Rbpj from neural tube
(red), and RNA-seq from FACS-isolated Ptf1a lineage cells from E11.5 Ptf1a+/ (gray) or Ptf1a/ embryos (black). Seven Ptf1a peaks are highlighted with
yellow bars. The location of the Prdm13 transcript is shown, as is a histogram of mammalian conserved regions (UCSC Genome Browser).
(B) Sequence under the apex of each Ptf1a ChIP-seq peak. DNA regions 1–7 showing the E-box (blue), TC-box (red), and the PTF1 motifs (underlined). Asterisks
denote peaks that are conserved from mouse to zebrafish and contain the consensus PTF1 motif.
(C and D) Overexpression of mouse Ptf1a (C, red) in chick neural tube induces cPrdm13 mRNA (D, arrowheads). Inset: GFP indicates the electroporation
efficiency.
(E) Diagram of section planes for images shown in (F)–(I).
(F–J00) Cross-sections of mouse E11.5 or E16.5 show Ptf1a protein in wild-type (F–J), or Prdm13 mRNA in wild-type (F0–J0) and Ptf1a-/- (F00–J00). Note that in
cerebellum, diencephalon, and retina, Prdm13 is lost in the Ptf1a mutant, but in the spinal cord, only the lateral domain that reflects the Ptf1a pattern is lost
(arrows).
Figure S2 includes expression data for Ptf1a andPrdm13 in the neural tube at additional embryonic stages and genomic coordinates for Ptf1a peaks 1–7 from (B).
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specific and is almost exclusively restricted to Ptf1a domains
(Figures 2E–2J0). At E10.5–E12.5, Ptf1a is present in the dorsal
neural tube from spinal regions (Figures 2I and 2I0; Figure S2)
to the developing cerebellum (Figures 2F and 2F0) and in a subset
of cells in the diencephalon (Figures 2G–2H0). Prdm13 is present
in all these domains, including the retina at E16.5 (Figures 2J and
2J0), but is not detected in the pancreas, the other major site of
Ptf1a expression. Notably, in the caudal neural tube, although
Prdm13 is restricted to the dorsal region, it appears to be present
more broadly in the ventricular zone than Ptf1a. Prdm13 overlaps
progenitor regions from dI2-dI6 (Figure 2I0; Figure S2) and is ex-Devepressed from E9 to E14.5 (Figure S2). However, even in the neu-
ral tube, Prdm13 appears enriched in the Ptf1a domains. In Ptf1a
null embryos, Prdm13 is abolished in rostral domains (Figures
2F00–2H00), indicating that expression of Prdm13 in these regions
is dependent on Ptf1a. Within the caudal neural tube, Prdm13
mRNA is reduced only at the lateral border of the ventricular
zone where Ptf1a is expressed (Figures 2I–2I00, arrows; Fig-
ure S2), suggesting that Ptf1a-independent mechanisms also
regulate Prdm13 in this region.
In summary, the neural restricted patterns of Prdm13 and
Ptf1a are strikingly similar, with a major component of Prdm13
expression being Ptf1a dependent. Together with the ChIP-seqlopmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier Inc. 185
Figure 3. Ptf1a and Prdm13 Induce Inhibitory, and Suppress Excitatory, Neuronal Markers
Stage HH12-13 chick embryos were electroporated with empty vector (control), Ptf1a, Prdm13, or both Ptf1a and Prdm13. Transverse sections through stage
HH24-25 are shown with the electroporated side on the right.
(A–D) GFP (green) shows electroporation efficiency along the dorsoventral axis. Ptf1a protein (red) and Prdm13mRNA show ectopic expression. Dashed box in
(A) is the region of the neural tube shown in (A0)–(D00) and (O)–(R). (A0–D00) Dorsal neural tube sections from (A)–(D) indicate the dI3 and dI5 neuronal populations
marked by Tlx1/3 or the dI4 neurons marked by Pax2.
(E and F) the ratio of Tlx1/3+ or Pax2+ neurons on the electroporated side versus the control side showing that overexpression of Ptf1a and Prdm13 cause a
dramatic decrease in Tlx1/3+ and increase in Pax2+ neurons relative to control. Note that ectopic Pax2+ cells (white arrowheads) are found in the dI5 domain not
normally expressing Pax2 (yellow arrowhead).
(legend continued on next page)
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downstream target of Ptf1a.
Prdm13 Phenocopies Ptf1a Function in the Dorsal
Neural Tube
To begin to uncover the function of Prdm13 during neural devel-
opment, we misexpressed mouse Ptf1a and Prdm13 in chick
neural tubes at stage HH12-13 via in ovo electroporation. The
exogenous expression was confirmed by specific immunofluo-
rescence for Ptf1a and mRNA in situ hybridization for Prdm13
(Figures 3B–3D), while GFP indicated electroporation efficiency
across the dorsoventral axis (Figure 3A). Transverse sections of
thoracic neural tube were collected at HH24-25 and examined
by immunofluorescence for alterations in neuronal subtype
specification relative to the nonelectroporated side. Ectopic
expression of either Ptf1a or Prdm13 dramatically decreased
the number of Tlx1/3+ cells (2.5- and 2.0-fold, respectively),
while increasing the number of dI4 Pax2+ cells (1.5-fold in
each case) (Figures 3B0–3C00, 3E, and 3F). Electroporation of
empty vector, in contrast, did not alter the number of the
neurons generated in either population (Figures 3A0–3A00, 3E,
and 3F). Coelectroporation of Prdm13 and Ptf1a together
more strongly induced Pax2 expression than either alone (Fig-
ures 3D00–3F). Similar trends were seen with additional markers
for dorsal interneuron populations, including Isl1/2, Lmx1b,
and Lhx1/5 (Figure S3).
Because other members of the PRDM family are primarily re-
pressors, we hypothesized that Prdm13 might induce Pax2 by
indirect means, such as by relieving repression by another fac-
tor. For example, derepression of Lbx1, which induces Pax2 in
the absence of Tlx1/3 (Cheng et al., 2005), might account for
the increase in Pax2 levels seen with Prdm13 misexpression.
Indeed, Lbx1 was also induced by ectopic expression of Ptf1a
and Prdm13, particularly in regions dorsal to its native domain
(Figures 3O–3S, arrows). Because Ptf1a and Prdm13 also inhibit
Tlx3 in the dI3 domain, the induction of Pax2 may be indirect
through the unopposed activity of ectopic Lbx1.
In the dorsal neural tube, Tlx1/3 cells give rise to vGlut2+ excit-
atory neurons, and Pax2 cells give rise to Gad1+ inhibitory neu-
rons. To determine whether Ptf1a and Prdm13 are sufficient to
modulate the neurotransmitter phenotypes as well, we per-
formed mRNA in situ hybridization for Gad1 and vGlut2 on the
electroporated neural tubes. An increase in Gad1 and decrease
in vGlut2 confirms that the ectopic Pax2-expressing neurons
from Ptf1a and Prdm13 overexpression adopt a GABAergic
identity (Figures 3T–3W0, arrows indicating dI3 and dI5 regions
with ectopic Gad1 or reduced vGlut2). Thus, Prdm13 serves a
similar function as Ptf1a by promoting the Pax2+ GABAergic line-
age and suppressing the Tlx1/3+ glutamatergic fate.(G–N) Electroporated cells, visualized by GFP, colocalized with Tlx1/3 (G–J) or P
dorsal mantle zone is shown. Ectopic expression of Ptf1a and/or Prdm13 reduces
increases Pax2;GFP double-positive cells from 12% to 39%–53%.
(O–S) Dorsal neural tube sections from (A)–(D) showing the dI4-6 neuronal pop
overexpression cause an increase in Lbx1+ neurons relative to control. The whit
normally expressing Lbx1 (compare to control, O, yellow arrowhead).
(T–W0) In situ hybridization with Gad1 or vGlut2 probes showing that Ptf1a and Pr
when compared to either the empty vector control (yellow arrowheads) or the co
(X) Diagram summarizing the overexpression phenotypes. Error bars are reporte
Figure S3 includes analysis of the Prdm13 phenotype with additional markers of
DeveA closer look at the pattern of Pax2+ neurons in the Ptf1a and
Prdm13 electroporated neural tubes revealed that the normal dI5
gap between dI4 and dI6 was filled with Pax2+ cells (Figure 3,
compare 3A00 with 3B0–3C00, arrows). This suggested that ectopic
expression of Ptf1a and Prdm13 alter the fate of progenitor cells,
an interpretation consistent with previous conclusions from
analysis of the Ptf1a knock out mouse (Glasgow et al., 2005).
Indeed, closer examination of the dI3-dI5 domain revealed that
Prdm13 electroporated cells are strongly biased to a Pax2+:
Tlx1/3- fate (Figures 3G–3N). In the empty vector control, 34%
of the dorsal GFP+ cells were Tlx1/3+. When Ptf1a, Prdm13, or
both were ectopically expressed, GFP+:Tlx1/3+ cells were rarely
seen, and the percentage dropped to 2%–4% (Figures 3H–3J).
In contrast, the number of dorsal GFP+:Pax2+ cells increased
from 12% in the control to 39%–40% with ectopic Ptf1a or
Prdm13 (Figures 3L–3M). The percentage increased to 53%
GFP+;Pax2+ cells when Ptf1a and Prdm13 were introduced
simultaneously, consistent with the collaborative effect noted
above (Figure 3N). We confirmed that the loss of Tlx1/3+ cells
and enrichment of Pax2+ cells is not an artificial result of selective
cell death, as assayed by immunostaining for Caspase 3 (data
not shown). These findings indicate that both Ptf1a and its target
Prdm13 can alter the fate of progenitor cells and bias them to the
Pax2+/inhibitory neuronal lineage.
Knockdown of Ptf1a or Prdm13 Leads to a Reduction of
Pax2+ Cells
To gain further insight into the role of Prdm13 in neuronal spec-
ification, we generated specific short hairpin RNAs (shRNA) to
knockdown endogenous Ptf1a or Prdm13 in the chick neural
tube. Constructs containing shRNAs to Ptf1a, Prdm13, orDsRed
(control) were electroporated as above (Figures 4A–4C), and
mRNA in situ hybridization was performed to verify knockdown
(Figures 4H–4K, black arrows). Reduction of Ptf1a and Prdm13
levels led to a marked decrease in the number of Pax2+ cells
(1.7- and 2.0-fold for knockdown of Ptf1a and Prdm13, respec-
tively) (Figures 4B00–4C00 and 4G). There was a modest increase
in the number of Tlx1/3+ cells with Prdm13 knockdown; how-
ever, in the Ptf1a knockdown there was no significant difference
(Figures 4B0–4C0 and 4F). Electroporation of control shRNA
altered neither the expression of Tlx1/3 nor Pax2 (Figures 4A0–
4A00, 4F, and 4G). There was no increase in cell death in electro-
porated hemicords as detected by Caspase3 expression (data
not shown). Misexpression of mouse Ptf1a or Prdm13 with their
respective shRNA constructs rescued the knockdown pheno-
types, demonstrating specificity of the shRNA (Figure S4). These
results demonstrate that Prdm13, like Pft1a, is required to
generate the correct number of Pax2+ neurons in the dorsal
spinal cord.ax2 (K–N). The percentage of GFP cells that coexpress Tlx1/3 or Pax2 in the
the percentage of Tlx1/3;GFP double-positive cells from 34% to 2%–4% and
ulations marked by Lbx1. Quantification (S) showing that Ptf1a and Prdm13
e arrowheads indicate ectopic Lbx1 expression detected in the dI3 region not
dm13 overexpression increase Gad1 and decrease vGlut2 (black arrowheads)
ntrol side in each neural tube.
d as SEM. *p values < 0.001.
the dorsal interneuron populations, including Isl1/2, Lmx1b, and Lhx1/5.
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Figure 4. Ptf1a Requires Prdm13 to Specify Inhibitory Neurons and Suppress Excitatory Neurons
Stage HH12-13 chick embryos were electroporated with expression or shRNA vectors to modulate levels of Ptf1a and Prdm13. Transverse sections through
stage HH24-25 are shown with the electroporated side on the right. (A–E) GFP indicates the electroporation efficiency along the dorsoventral axis. The dashed
box is the region shown in (A0)–(E00). (A0–E0 and F) Tlx1/3 shows Prdm13 knockdown results in an increase in dI3/dI5 neurons (C0). Epistasis experiments show
Prdm13 does not require Ptf1a for this activity in repressing Tlx1/3 (D’), but Ptf1a activity is abrogated with shPrdm13 (E0). (A00–E0 0 and G) Pax2 shows a significant
decrease in the number of dI4 neurons when Ptf1a or Prdm13 are knocked down compared to control shRNA (B00, C00, and G). Epistasis experiments show
Prdm13 does not require Ptf1a for this activity in inducing Tlx1/3 (D’’), but Ptf1a activity is abrogated with shPrdm13 (E00). Note that ectopic Pax2+ cells (white
arrowhead) are found in the dI5 domain not normally expressing Pax2 (yellow arrowheads). Error bars are reported as SEM. p values < 0.001 between sample
and control (*) and between samples (#). NS, not significant. (H–K) cPtf1a or cPrdm13 probes indicate the knockdown efficiency (arrows). Inset: GFP indicates
the electroporation efficiency. (L) Diagram summarizing the conclusion that Prdm13 is a functional downstream target of Ptf1a that induces Pax2 and
suppresses Tlx1/3.
Figure S4 includes rescue control experiments for the shRNA.
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Tlx1/3+ Cells
Results detailed above strongly suggest that Prdm13 functions
as a downstream effector of Ptf1a during neuronal subtype
specification. If Prdm13 is required for Ptf1a activity, then knock-
ing down Prdm13 when Ptf1a is ectopically expressed should
abrogate Ptf1a activity. Indeed, the increase in Pax2+ cells and
the decrease in Tlx1/3+ cells normally seen with ectopic Ptf1a
expression was inhibited when Prdm13 was simultaneously
knocked down (Figures 4E0–4E00, 4F, and 4G, compare with
gray bar). Conversely, knockdown of Ptf1a did not affect the
activity of ectopically expressed Prdm13, consistent with Ptf1a
acting upstreamof Prdm13 (Figures 4D0–4D00, 4F, and 4G). These
experiments support the requirement for Prdm13 as a down-
stream effector of Ptf1a.
Prdm13 Requires Its Zinc-Finger Motifs for Activity and
Acts as a Repressor
The PRDM family of transcription factors is characterized by
a PR domain and a variable number of zinc fingers, but the func-
tional contribution of each of these domains remains unclear for
any given member of the family (for review, see Fog et al., 2012;
Hohenauer and Moore, 2012). To better understand the mecha-
nism behind Prdm13 function, we generated mutants of Prdm13
and tested their activity in chick neural tube (Figures 5A–5C).
Although the PR domain has been shown to be critical for the
function of other PRDM family members, this domain was
dispensable for Prdm13 activity, as the truncated form of
Prdm13 containing the four zinc fingers (Z1234) retained full ac-
tivity (Figures 5B and 5C, representative images are shown in
Figures S5I0 and S5I00). Furthermore, the zinc fingers themselves
are required for Prdm13 activity because mutations designed to
disrupt these domains (Prdm13mZ1234) also disrupted Prdm13
function (Figures 5B and 5C; Figures S5J0 and S5J00).
Members of the PRDM family of factors have been reported
to function either as transcriptional repressors or activators
depending on the cellular context. To determine whether the
neuronal specification activity observed with Prdm13 reflects
its function as a transcriptional repressor or an activator, we
fused it with engrailed repressor (EnR) (Smith and Jaynes,
1996) or with the VP16 activator (Triezenberg et al., 1988) and
tested these chimeric proteins for activity in the chick neural
tube. The activity of Prdm13-EnR was indistinguishable from
that of wild-type Prdm13 in that the number of Tlx1/3+ neurons
was dramatically reduced, while Pax2+ neurons increased (Fig-
ures 5B and 5C; Figure S5). In contrast, expression of Prdm13-
VP16 resulted in a decrease in Pax2+ cells. Prdm13-VP16 also
slightly repressed Tlx1/3, although the effect was much less
pronounced than that of Prdm13-EnR or Prdm13 (Figures 5B
and 5C; Figure S5). Taken together, Prdm13 appears to exert
its effects by acting as a transcriptional repressor, an activity
that requires its zinc-finger domains.
Prdm13 Suppresses Generation of Tlx1/3+ Neurons by
Antagonizing Ascl1 Activity
Given that the bHLH factor Ascl1 specifies opposing programs
(dI3 and dI5) to Ptf1a and Prdm13 at this stage (Figure 1) (Bro¨hl
et al., 2008; Helms et al., 2005; Mizuguchi et al., 2006; Nakada
et al., 2004), we hypothesized that Prdm13 might functionDevethrough interfering with Ascl1 activity. We tested this by coelec-
troporating Ascl1 and Prdm13 into the chick neural tube. Ectopic
Ascl1 results in a dramatic increase of Tlx1/3+ neurons and a loss
of Pax2+ neurons (Figures 5D0–5D00, 5F, and 5G). Strikingly, when
Ascl1 and Prdm13 are expressed simultaneously, Ascl1 is no
longer able to induce Tlx1/3. Instead, we observed a 3.3-fold
decrease in Tlx1/3+ neurons and a 1.6-fold increase in Pax2+
cells relative to the control side, similar to effects of Prdm13mis-
expression alone (Figures 5E0–5E00, 5F, and 5G, compare with
Figures 3C0–3C00, 3E, and 3F). Prdm13 does not alter endoge-
nous Ascl1 levels (Figures S5A0, S5B0, and S5C); therefore,
Prdm13 antagonizes Ascl1 activity without inhibiting expression
of Ascl1 itself. Thus, although Ascl1 is expressed in both progen-
itors to dI4 and dI5 neurons, it is the presence or absence of
enriched Prdm13 levels that dictate the decision between these
cell fates.
Prdm13 Complexes with Ascl1 to Directly Repress Tlx3
Expression
We used ChIP-seq to localize Prdm13 to chromatin in vivo as a
means to uncover how Prdm13 suppresses expression of Tlx1
and Tlx3. We performed ChIP-seq with antibodies to Prdm13
using chromatin from E11.5 neural tubes. We found Prdm13
enriched at regions upstream of both the Tlx1 and Tlx3 genes
(Figure 6A). No enrichment was detected with these antibodies
in chromatin isolated from E11.5 mouse telencephalon tissue
where Prdm13 is absent (Figure 6A). Furthermore, Prdm13 was
not found within a 300 kb region surrounding the Pax2 gene,
consistent with Prdm13 induction of this gene being indirect.
Enrichment of the Tlx1 and Tlx3 regions was confirmed in ChIP
quantitative real-time PCR experiments. Again, there was
enrichment of the Tlx1 and Tlx3 sites in neural tube that was
not seen with telencephalon tissue or with a control genomic
region (Figure 6B). These data suggest that Prdm13 inhibits glu-
tamatergic identity by binding near the glutamatergic-specifier
genes Tlx1 and Tlx3 and directly repressing their transcription.
This in turn may facilitate Lbx1-mediated induction of Pax2
and GABAergic neuronal specification (see Figure 7 for model).
To explore how Prdm13 antagonizes Ascl1, we asked whether
Ascl1 was also found at the Prdm13-bound Tlx1 and Tlx3 sites.
ChIP with Ascl1 antibodies from E11.5 neural tubes showed sig-
nificant enrichment at the Tlx3 site but not at the Tlx1 site (Fig-
ure 6C). This enrichment was similar to that seen with a known
target of Ascl1, Dll1 (Castro et al., 2006). Enrichment at the
Tlx3 site was not detected from limb tissue where Ascl1 is not
expressed or from a control genomic region. This finding sug-
gests a model whereby Ascl1 binds and activates expression
of Tlx3, but when Prdm13 levels increase downstream of Ptf1a,
a novel transcription repressor complex that includes Ascl1
and Prdm13 is formed. Supporting this model, specific binding
between Ascl1 and Prdm13 is detected in coimmunoprecipita-
tion (coIP) experiments when epitope-tagged versions of the
proteins are expressed in HEK293 cells (Figure 6D).
Two distinct mechanisms, one Ascl1-dependent and one
Ascl1-independent, are suggested for Prdm13 suppression of
the glutamatergic gene expression program in cells fated to
become GABAergic neurons (see Figure 7). To verify that
Prdm13- and Ascl1-bound regions function as enhancers,
we tested reporter constructs derived from the Tlx1 and Tlx3lopmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier Inc. 189
Figure 5. Prdm13 Blocks Ascl1 Activity through Repression Requiring Its Zinc Fingers
(A) Diagram of the Prdm13 mutations tested. PR domain (red boxes) and zinc-finger domains (blue boxes) are indicated. Engrailed repressor (EnR) or activator
VP16 were fused in frame at the C-terminal end of Prdm13.
(B and C) Quantification of experiments testing the Prdm13 mutants indicated. The black dashed line indicates the pCIG control ratio of injected/control side.
The gray dashed line indicates the phenotype of the full-length Prdm13. The PR domain is dispensable for Prdm13 activity, but the four zinc fingers are required.
The Prdm13-EnR fusion mimics the Prdm13 phenotype, whereas the Prdm13-VP16 does not.
(D–E00) Stage HH12-13 chick embryos were electroporated with Ascl1 (D) or Ascl1 plus Prdm13 (E). Transverse sections through stage HH24-25 are shown
with the electroporated side on the right. Ascl1 antibodies detect the ectopically expressed protein (blue), and Prdm13 is indicated by GFP. Dashed lines indicate
location of the ventricle. Dorsal neural tube sections from (D) and (E) show Tlx1/3 defining the dI3 and dI5 (D0–E0) and Pax2 defining dI4 neuronal populations
(D00–E00). Ectopic Ascl1 causes a dramatic increase in the number of Tlx1/3+ neurons with a decrease in Pax2+ cells, whereas addition of Prdm13 reverses this
phenotype.
(F and G) The ability of Prdm13 to block this activity of Ascl1 is quantitatively shown.
All error bars are reported as SEM. p values < 0.001 between sample and control (*), and between samples (#). NS, not significant. Diagram summarizing
the conclusion that Prdm13 antagonizes Ascl1 neuronal subtype specification activity. Figure S5 shows Ascl1 expression levels are not altered by over-
expression or knockdown of Prdm13. Additionally, representative images for Tlx1/3 and Pax2 for chick electroporation experiments with the Prdm13 truncations
are shown.
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porated into the chick neural tube at HH12-13 and assayed 48 hr
later. Strikingly, eTlx3::GFP was largely restricted to the dI3 and
dI5 domains and eTlx1::GFP to the dI5 domain, reflecting the
expression of their respective gene loci (Figures 6E and 6I).
Furthermore, coelectroporation of the reporter constructs with
Ascl1 resulted in a dramatic induction of eTlx3::GFP and only a190 Developmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier Islight induction of eTlx1::GFP, consistent with Ascl1 localizing
to Tlx3, but not Tlx1 (Figures 6F, 6J, 6M, and 6N). This dramatic
activation of eTlx3::GFP by Ascl1 was abrogated when Prdm13
was also expressed (Figures 6H and 6L). Misexpression of
Prdm13 alone with the reporter constructs similarly inhibited
their activity in dI3 and dI5 domains (Figures 6G and 6K). Thus,
in addition to identifying enhancers for Tlx1 and Tlx3 that arenc.
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whereby Prdm13 may be recruited to the Tlx3 enhancer with
Ascl1 to directly repress Tlx3.
DISCUSSION
A balance of excitatory and inhibitory neuronal input is crucial for
normal nervous system function. Because dorsal horn neurons in
the spinal cord form the first level of central processing of
somatosensory input from the periphery, this balance is required
for normal perception of pain, touch, and sense of body position.
Generation of neuronal diversity in the spinal cord involves the
specification of GABAergic and glutamatergic neurons from
neighboring and interspersed progenitors in the dorsal neural
tube ventricular zone just as they are transitioning to postmitotic
neurons. The network of transcription factors required for this
process includes members of the bHLH and HD families. In
particular, Ascl1+-proliferating progenitors in the dorsal neural
tube are competent to become either glutamatergic during early
neurogenesis (around E10.5) or bothGABAergic and glutamater-
gic after E12.5. In the absence of Ptf1a, Ascl1 induces expres-
sion of Tlx1/3 and Lmx1b. These HD factors in turn induce the
glutamatergic program while suppressing the ability of Lbx1 to
induce Pax2 and the GABAergic program (Cheng et al., 2005;
Helms et al., 2005) (see Figure 7 for model). In contrast, a subset
of these Ascl1+ progenitors begins to express Ptf1a, which acti-
vates expression of the HD factors Pax2 and Lhx1/5 and the
resulting GABAergic program (Glasgow et al., 2005; Wildner
et al., 2006) (Figure 7). However, for correct specification of these
neurons, the glutamatergic program must be repressed. Here,
we identify the zinc-finger transcription factor Prdm13 that pro-
vides this critical function through repression of Ascl1 activity
and direct repression of Tlx1 and Tlx3 expression (Figure 7).
Mechanisms of Prdm13Action inNeuronal Specification
The PRDM family of factors is interesting in the variety of mech-
anisms they reportedly use to regulate transcription (for review,
see Fog et al., 2012; Hohenauer and Moore, 2012). They contain
two major recognizable motifs, the PR domain and zinc fingers.
The PR domain is similar to the SET domain found in histone
lysine methyltransferases (HMT), and thus, some members of
the PRDM family have been shown to have this enzymatic activ-
ity. However, the sequence homology between PR domains and
the SET domain reveals that the PR domain of Prdm13 is sub-
stantially divergent. We show that the PR domain is dispensable
for Prdm13 activity in our assays because a truncated Prdm13
(amino acids 185–755) that lacks the PR domain but contains
all four zinc fingers is sufficient to induce Pax2+ cells and repress
Tlx1/3 at levels similar to that seen with the full-length protein.
Furthermore, the zinc fingers are required for Prdm13 function
because mutations designed to disrupt each zinc finger abol-
ished Prdm13 activity (Figure 5).
Zinc-finger domains in other PRDM factors have been shown
to be involved in a variety of activities including DNA binding,
protein-protein interaction, intrinsic HMT activity, and recruit-
ment of other histone-modifying proteins. Prdm1, 3, 5, 9,
and 14 can directly bind DNA (Fog et al., 2012). In contrast,
Prdm8, which shows the highest similarity to Prdm13, does
not directly bind DNA but rather binds chromatin in a complexDevewith Bhlhb5 (Ross et al., 2012). Results from Prdm13 ChIP indi-
cate it localizes with chromatin, but, like Prdm8, it may do so
indirectly. This is supported by three findings in our data. First,
for efficient ChIP, a long-arm crosslinker compound treatment,
ethylene glycol-bis (succinimidyl succinate) (Zeng et al., 2006),
was required. Second, no zinc-finger-type binding motif was
identified from the ChIP-seq results in regions bound by
Prdm13 (data not shown). And, third, we provide evidence for
Prdm13 interacting with Ascl1 to repress Ascl1 target genes
(Figure 6). However, these results do not exclude the possibility
that Prdm13 also binds DNA directly. Indeed, ChIP for Prdm13
in Ascl1 mutant neural tubes still showed Prdm13 bound to
the Tlx3 enhancer (data not shown). Thus, Prdm13 is functioning
through mechanisms distinct from those seen with Prdm8 and
may repress its targets by combinations of direct and indirect
binding to DNA.
Here, we demonstrate that Prdm13 is a key factor in ensuring
that glutamatergic lineage genes are silenced during generation
of GABAergic neurons. Prdm13 suppresses the glutamatergic
lineage and induces the GABAergic lineage through transcrip-
tional repression of the glutamatergic specifier factors Tlx1 and
Tlx3 (Figure 7). This is supported by the fact that (1) ectopically
expressed Prdm13 reduces the number of Tlx1/3+ cells in the
dorsal neural tube, (2) Prdm13 functions as a transcriptional
repressor, (3) Prdm13 occupies genomic regions near both the
Tlx1 and Tlx3 genes in sequence conserved across mammalian
species, and (4) Prdm13-bound Tlx1 and Tlx3 regions have
enhancer activity that was blocked by ectopic Prdm13. Because
Prdm13 was not localized to the Pax2, Lhx1/5, or Lbx1 genes
(Figure 6; data not shown), and Prdm13 is acting as a transcrip-
tional repressor, the increase in expression of these GABAergic
lineage genes upon overexpression of Prdm13 is likely indirect.
Indeed, induction of Pax2 can be explained by Prdm13’s direct
suppression of Tlx1 and Tlx3, known to block Lbx1 induction
of Pax2 as mentioned above (Cheng et al., 2005) (see model in
Figure 7).
Additional Functions for Prdm13
Ptf1a not only functions in specifying the excitatory/inhibitory
balance in the dorsal spinal cord, but it also controls the balance
of GABAergic interneurons with that of the glutamatergic granule
cells in the cerebellum (Hoshino et al., 2005; Pascual et al., 2007).
Similarly, Ptf1a is required in the retina for generation of
GABAergic and glycinergic amacrine and horizontal neurons
and suppression of glutamatergic retinal ganglia neurons (Dullin
et al., 2007; Fujitani et al., 2006; Jusuf and Harris, 2009; Nakhai
et al., 2007). By mRNA in situ hybridization, Prdm13 reflects
Ptf1a in cerebellum and retina, and in Ptf1a mutants, Prdm13
is dramatically attenuated in these domains. This suggests
Prdm13 may suppress non-Ptf1a lineage gene expression in
these regions as it does in the dorsal neural tube.
Non-Ptf1a-dependent activities are also suggested by
Prdm13 expression detected as early as E9 in the dorsal neural
tube ventricular zone (Figure S1). This ventricular zone expres-
sion spans the region where dI2 to dI6 arise, and it is not affected
in the Ptf1a mutant. A hint that Prdm13 may also function
in neuronal proliferation and differentiation was seen in the
Prdm13 overexpression experiments in chick. Normally, Ascl1
drives neuronal differentiation when overexpressed; however,lopmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier Inc. 191
Figure 6. Prdm13 Directly Suppresses Tlx1 and Tlx3 through Multiple Mechanisms
(A) UCSC Genome Browser showing mouse genomic regions surrounding Tlx3, Tlx1, and Pax2, including Prdm13 ChIP-seq from neural tube (NT, blue), and two
negative controls, including Prdm13 ChIP-seq, from telencephalon (Tel) and input from NT, all from E11.5 mouse embryos. Prdm13 occupies chromatin near the
Tlx1 and Tlx3 genes at sequence conserved across mammals (yellow highlight). Green bars labeled eTlx1 and eTlx3 are the regions used in the GFP reporter
constructs in (E)–(N).
(B) ChIP quantitative real-time PCR validating Prdm13 ChIP-seq at the eTlx1 and eTlx3 loci in (A). Tel tissue is negative for Prdm13 and serves as a control for
specificity of the antibody.
(C) ChIP quantitative real-time PCR for Ascl1 at the eTlx1 and eTlx3 loci in (A). Limb tissue is negative for Ascl1 and serves as a control for specificity of the
antibody. eDll1 is a known target of Ascl1.
(D) coIP experiments of epitope-tagged versions of the proteins transfected into HEK293 cells indicate specific interaction between Ascl1 and Prdm13 (lane 5),
but not the negative control, myc-Hook3 (lane 6).
(legend continued on next page)
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Figure 7. Transcriptional Network Controlling the Balance of Inhibi-
tory and Excitatory Neurons in the Dorsal Spinal Cord
Progenitors in the ventricular zone express Ascl1. In the absence of Ptf1a,
these cells become excitatory neurons (dP5 lineage) through Ascl1 induction
of the HD factors Tlx1/3 and Lmx1b. Tlx1/3 repress the Lbx1-dependent in-
duction of Pax2 and the inhibitory neuronal program. Ascl1 regulates Tlx3
directly, whereas Tlx1 may be indirect. Ptf1a is upregulated in a subset of the
Ascl1 progenitor cells, functioning to direct their fate to inhibitory neurons (dP4
lineage) through induction the HD factors Pax2 and Lhx1/5. Additionally, Ptf1a
directly increases levels of Prdm13 that in turn suppress Tlx1 and Tlx3,
ensuring a suppression of the glutamatergic program in the inhibitory neurons.
Prdm13 works through at least two mechanisms; one being Ascl1-dependent
possibly involving a novel transcriptional repressor complex for Tlx3-like
genes, and the other Ascl1-independent requiring some other activator (green
circle) for Tlx1-like genes.
Developmental Cell
Prdm13 Regulates Neuronal Subtype Specificationwhen Prdm13 was coexpressed with Ascl1, it disrupted this
phenotype (Figure 5, compare the distribution of Ascl1+ cells in
D and E). Thus, Prdm13 may function to modulate Ascl1 activity
(and other bHLH factors) in their role in neuronal differentiation as
well as their role in controlling cell-fate decisions.
Switching Ascl1 from Transcriptional Activator to
Repressor
Ascl1 has been shown to be essential in the development of
multiple neural and neuroendocrine lineages, particularly during
early stages of differentiation from progenitors (Bertrand et al.,
2002). Most recently it was identified as an essential component
of a transcription factor cocktail that can directly reprogram or
transdifferentiate fibroblasts to neurons (Yang et al., 2011). At a
mechanistic level, Ascl1 heterodimerizes with E-proteins (such
as Heb and E2a), binds DNA, and activates transcription (John-
son et al., 1992). Interactions with the global coactivator p300, a
histone acetyltransferase, have been reported (Yamamoto et al.,
2001). Our current findings suggest Ascl1 may make a repressor
complex with Prdm13, switching Ascl1 from an activator to a
repressor with respect to the glutamatergic-specifier gene
Tlx3. Supporting this model (Figure 7), we show that (1) Ascl1
and Prdm13 localize to the same genomic location upstream(E–N) Chick neural tube electroporated with either eTlx3::GFP or eTlx1::GFP repo
electroporated side is shown, and the neural tube is outlined with a dashed line.
Tlx1/3 (yellow arrowheads). (E0–H) Ascl1 dramatically induces eTlx3::GFP, and thi
(yellow arrowhead). (I0–L) Induction by Ascl1 is more subtle than that seen with e
dicates the electroporation efficiency. (M and N) The quantification of these data
0.001 relative to control or between samples indicated.
Deveof the Tlx3 gene, (2) Ascl1 and Prdm13 coimmunoprecipitate,
and (3) Ascl1 induces expression of the Tlx1- and Tlx3-enhancer
reporters, activities repressed by Prdm13. An alternative model
would have Prdm13 blocking Ascl1 from binding the Tlx3
enhancer. Further experiments are required to definitively distin-
guish between these models. Nevertheless, Prdm13 is instru-
mental to silencing the gene program for the glutamatergic fate
via Ascl1 as cells progress toward the GABAergic neuronal
lineage.
In summary, PRDM factors utilize diverse mechanisms to
modulate transcription and broadly function in progenitor popu-
lations to control lineage decisions. This study places Prdm13, a
zinc-finger transcription factor, in a critical role connecting the
neuronal specification functions of bHLH and HD factors and
highlights the importance of silencing transcription of gene pro-
grams in the opposing lineage.
EXPERIMENTAL PROCEDURES
Mouse Strains and Tissue Preparation
Mutant mouse strains have been previously described. Ptf1aCre (p48Cre),
where the Ptf1a coding region is replaced by that coding for Cre recombinase,
was used as the Ptf1a null (Kawaguchi et al., 2002). 12.4Ptf1a::mCherry trans-
genic mice, where a 12.4 kb regulatory sequence from 30 of the Ptf1a gene
drives expression of mCherry (Meredith et al., 2009), was used for fluores-
cence-activated cell sorting (FACS) of Ptf1a lineage cells from E11.5 wild-
type or Ptf1a null neural tubes. PCR genotyping was performed as previously
described (Glasgow et al., 2005; Meredith et al., 2009). All procedures on
animals follow the National Institutes of Health’s guidelines andwere approved
by the UT Southwestern Institutional Animal Care and Use Committee.
Chromatin Immunoprecipitation and Library Preparation for
Sequencing
Tissue source for ChIP was mouse E11.5 or 12.5 neural tubes. Ptf1a-, Ascl1-,
and Prdm13-negative tissue for control included telencephalon and/or limbs
from the same embryos. ChIP was performed as previously described
(Holmstrom et al., 2011; Masui et al., 2007), with details in the Supplemental
Experimental Procedures. Notably, the Prdm13 ChIP was treated with formal-
dehyde along with the long-arm crosslinker, ethylene glycol-bis (succinimidyl
succinate), to increase ChIP efficiency (Zeng et al., 2006). Antibodies used for
Ptf1a and Ascl1 ChIP are as published (Castro et al., 2006; Beres et al., 2006).
Lab-generated antisera were used for Rbpj (TX857, rabbit anti-Rbpj) and
Prdm13 (TX970, rabbit anti-Prdm13); details are provided in the Supplemental
Experimental Procedures. NEBNext ChIP-seq Sample Prep Master Mix Set 1
was used for library generation. Detailed methods and primers used for
ChIP quantitative real-time PCR are listed in the Supplemental Experimental
Procedures. ChIP efficiency (CE) was calculated relative to input as CE =
(2Ct input  Ct ChIP)3 DF 3 100%, where DF is the dilution factor between input
and ChIP sample.
Plasmid Description
FLAG-tagged Prdm13 and variations used for expression in the chick neural
tube were inserted into the pCIG vector, which drives expression through a
combined cytomegalovirus early-enhancer/chicken b-actin promoter and
contains an IRES-NLS-GFP (Megason and McMahon, 2002). Prdm13
mZ1234 contains point mutations in each zinc finger (Z1;C185A, H207A,
Z2;C622A, H638A, Z3;C650A, H666A, Z4;C679A, H695A). Ptf1a and Ascl1rter and expression vectors for Ascl1, Prdm13, or both as indicated. Only the
(E) The eTlx3::GFP signals are restricted and colocalize with dI3/dI5 markers,
s is blocked by Prdm13. (I) The eTlx1::GFP signals are restricted to dI5 neurons
Tlx3::GFP, but Prdm13 is still repressive. Inset: myc immunofluorescence in-
by measuring pixel intensity. Error bars are reported as SEM. * and # p value <
lopmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier Inc. 193
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Nakada et al., 2004). The Lbx1 expression vector was as described (Mu¨ller
et al., 2002). The engrailed repressor (EnR) (Smith and Jaynes, 1996) or the
VP16 activator (Triezenberg et al., 1988) was fused at the C-terminal end of
Prdm13 in pMiWIII. The eTlx1::GFP and eTlx3::GFP reporter constructs
include mm9 coordinates (eTlx1, chr19:45217747-45218583) and (eTlx3,
chr11:33134077-33134502), respectively, cloned into a GFP reporter cassette
with a b-globin basal promoter (Lai et al., 2011). All constructs used were
sequence verified.
The pSilencer 1.0-U6 vector (Ambion, Carlsbad, CA, USA) was used in
knockdown experiments in which several sets of 21-mer oligonucleotides
were selected from chick Ptf1a orPrdm13mRNA sequences (listed in the Sup-
plemental Experimental Procedures). Additionally, shRNA targeting DSred
was used as control (Rao et al., 2004). The shRNA constructs were coelectro-
porated with pCIG so the GFP could be used to assess electroporation
efficiency.
In Ovo Chick Electroporation
Fertilized white Leghorn eggs were obtained from the Texas A&M Poultry
Department (College Station, TX, USA) and incubated at 37C for 48 hr until
stage HH12-13 (Hamburger and Hamilton, 1992). Supercoiled plasmid DNA
(1–2.5 mg/ml each) were injected into the lumen of the closed neural tube,
and embryos were electroporated as previously described (Timmer et al.,
2001). After 48 hr incubation at 37C, stage HH24-25 embryos were harvested
and processed for immunofluorescence or in situ hybridization.
Immunofluorescence and In Situ Hybridization
Immunofluorescence was performed as previously described (Glasgow et al.,
2005; Hori et al., 2008). A list of primary antibodies used is provided in the
Supplemental Experimental Procedures. Fluorescence imaging was carried
out on a Zeiss LSM 510 confocal microscope. For each experiment, multiple
sections from at least six different embryos were analyzed and used for quan-
tification. Cell counting was blind to the condition andwas performedmanually
using ImageJ. The quantitative results are presented as a ratio of the number of
marker positive cells on the electroporated side divided by the number on the
nonelectroporated side. Only sections with confirmed high-efficiency expres-
sion across the dorsal ventral axis were used in the analysis. Mean GFP pixel
intensity for eTlx1/3::GFP expression was measured by ImageJ. Significant
differences between control and experimental samples were calculated using
a two-tailed two-sample equal variance (homoscedastic) Student’s t test
(* indicates p < 0.001) in Microsoft Excel. SEM is shown.
In situ hybridization was performed as previously described (Lai et al., 2011).
ChickGad1 and vGlut2 (Cheng et al., 2004) and chick Ptf1a (a gift from T. Reh)
probes were used. Plasmids for generating chick and mouse Prdm13 probes
were cloned by PCR into pBluescript with the primers listed in the Supple-
mental Experimental Procedures.
Coimmunoprecipitation
HEK293T cells were transfectedwith Flag-tagged Prdm13, myc-tagged Ascl1,
or Hook3 (control) expression constructs using FuGene 6 (Roche Life
Sciences, Branford, CT, USA) and collected 48 hr later. Anti-Flag antibodies
conjugated to protein A/G beads (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) were added to cleared lysate. Coimmunoprecipitation was assessed
by western blot using anti-myc (A-14, Santa Cruz, 1:2,000).
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2013.02.015.
ACKNOWLEDGMENTS
We acknowledge the many hours of helpful discussions with members of the
Johnson laboratory, particularly Dr. Tou Yia Vue. We are grateful for the
generosity of colleagues for antibody reagents, including Drs. T. Muller, C.
Birchmeier, E. Turner, T. Jessell, and R. MacDonald. This work was supported
by grants from the National Institutes of Health (F31NS705592) toM.D.B., (R21194 Developmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier INS067553, R01HD037932, andR01NS032817) to J.E.J., and (F31NS061440)
to D.M.M.
Received: April 23, 2012
Revised: January 5, 2013
Accepted: February 25, 2013
Published: April 29, 2013
REFERENCES
Batista, M.F., and Lewis, K.E. (2008). Pax2/8 act redundantly to specify glyci-
nergic and GABAergic fates of multiple spinal interneurons. Dev. Biol. 323,
88–97.
Beres, T.M., Masui, T., Swift, G.H., Shi, L., Henke, R.M., and MacDonald, R.J.
(2006). PTF1 is an organ-specific and Notch-independent basic helix-loop-
helix complex containing the mammalian Suppressor of Hairless (RBP-J) or
its paralogue, RBP-L. Mol. Cell. Biol. 26, 117–130.
Bertrand, N., Castro, D.S., and Guillemot, F. (2002). Proneural genes and the
specification of neural cell types. Nat. Rev. Neurosci. 3, 517–530.
Bro¨hl, D., Strehle, M., Wende, H., Hori, K., Bormuth, I., Nave, K.A., Mu¨ller, T.,
and Birchmeier, C. (2008). A transcriptional network coordinately determines
transmitter and peptidergic fate in the dorsal spinal cord. Dev. Biol. 322,
381–393.
Brzezinski, J.A., 4th, Lamba, D.A., and Reh, T.A. (2010). Blimp1 controls
photoreceptor versus bipolar cell fate choice during retinal development.
Development 137, 619–629.
Castro, D.S., Skowronska-Krawczyk, D., Armant, O., Donaldson, I.J., Parras,
C., Hunt, C., Critchley, J.A., Nguyen, L., Gossler, A., Go¨ttgens, B., et al. (2006).
Proneural bHLH and Brn proteins coregulate a neurogenic program through
cooperative binding to a conserved DNA motif. Dev. Cell 11, 831–844.
Cheng, L., Arata, A., Mizuguchi, R., Qian, Y., Karunaratne, A., Gray, P.A., Arata,
S., Shirasawa, S., Bouchard, M., Luo, P., et al. (2004). Tlx3 and Tlx1 are post-
mitotic selector genes determining glutamatergic over GABAergic cell fates.
Nat. Neurosci. 7, 510–517.
Cheng, L., Samad, O.A., Xu, Y., Mizuguchi, R., Luo, P., Shirasawa, S.,
Goulding, M., and Ma, Q. (2005). Lbx1 and Tlx3 are opposing switches in
determining GABAergic versus glutamatergic transmitter phenotypes. Nat.
Neurosci. 8, 1510–1515.
Dullin, J.P., Locker, M., Robach, M., Henningfeld, K.A., Parain, K., Afelik, S.,
Pieler, T., and Perron, M. (2007). Ptf1a triggers GABAergic neuronal cell fates
in the retina. BMC Dev. Biol. 7, 110.
Fitzgerald, M. (2005). The development of nociceptive circuits. Nat. Rev.
Neurosci. 6, 507–520.
Fog, C.K., Galli, G.G., and Lund, A.H. (2012). PRDM proteins: important
players in differentiation and disease. Bioessays 34, 50–60.
Fujitani, Y., Fujitani, S., Luo, H., Qiu, F., Burlison, J., Long, Q., Kawaguchi, Y.,
Edlund, H., MacDonald, R.J., Furukawa, T., et al. (2006). Ptf1a determines
horizontal and amacrine cell fates during mouse retinal development.
Development 133, 4439–4450.
Fumasoni, I., Meani, N., Rambaldi, D., Scafetta, G., Alcalay, M., and Ciccarelli,
F.D. (2007). Family expansion and gene rearrangements contributed to the
functional specialization of PRDMgenes in vertebrates. BMCEvol. Biol. 7, 187.
Glasgow, S.M., Henke, R.M.,Macdonald, R.J.,Wright, C.V., and Johnson, J.E.
(2005). Ptf1a determines GABAergic over glutamatergic neuronal cell fate in
the spinal cord dorsal horn. Development 132, 5461–5469.
Gowan, K., Helms, A.W., Hunsaker, T.L., Collisson, T., Ebert, P.J., Odom, R.,
and Johnson, J.E. (2001). Crossinhibitory activities of Ngn1 and Math1 allow
specification of distinct dorsal interneurons. Neuron 31, 219–232.
Gross, M.K., Dottori, M., and Goulding, M. (2002). Lbx1 specifies somatosen-
sory association interneurons in the dorsal spinal cord. Neuron 34, 535–549.
Hamburger, V., and Hamilton, H.L. (1992). A series of normal stages in the
development of the chick embryo. 1951. Dev. Dyn. 195, 231–272.
Helms, A.W., and Johnson, J.E. (2003). Specification of dorsal spinal cord
interneurons. Curr. Opin. Neurobiol. 13, 42–49.nc.
Developmental Cell
Prdm13 Regulates Neuronal Subtype SpecificationHelms, A.W., Battiste, J., Henke, R.M., Nakada, Y., Simplicio, N., Guillemot, F.,
and Johnson, J.E. (2005). Sequential roles for Mash1 and Ngn2 in the genera-
tion of dorsal spinal cord interneurons. Development 132, 2709–2719.
Henke, R.M., Savage, T.K., Meredith, D.M., Glasgow, S.M., Hori, K., Dumas,
J., MacDonald, R.J., and Johnson, J.E. (2009). Neurog2 is a direct down-
stream target of the Ptf1a-Rbpj transcription complex in dorsal spinal cord.
Development 136, 2945–2954.
Hohenauer, T., and Moore, A.W. (2012). The Prdm family: expanding roles in
stem cells and development. Development 139, 2267–2282.
Holmstrom, S.R., Deering, T., Swift, G.H., Poelwijk, F.J., Mangelsdorf, D.J.,
Kliewer, S.A., and MacDonald, R.J. (2011). LRH-1 and PTF1-L coregulate an
exocrine pancreas-specific transcriptional network for digestive function.
Genes Dev. 25, 1674–1679.
Hori, K., Cholewa-Waclaw, J., Nakada, Y., Glasgow, S.M., Masui, T., Henke,
R.M., Wildner, H., Martarelli, B., Beres, T.M., Epstein, J.A., et al. (2008). A
nonclassical bHLH Rbpj transcription factor complex is required for specifica-
tion of GABAergic neurons independent of Notch signaling. Genes Dev. 22,
166–178.
Hoshino, M., Nakamura, S., Mori, K., Kawauchi, T., Terao, M., Nishimura, Y.V.,
Fukuda, A., Fuse, T., Matsuo, N., Sone, M., et al. (2005). Ptf1a, a bHLH tran-
scriptional gene, defines GABAergic neuronal fates in cerebellum. Neuron
47, 201–213.
Johnson, J.E., Birren, S.J., Saito, T., and Anderson, D.J. (1992). DNA binding
and transcriptional regulatory activity of mammalian achaete-scute homolo-
gous (MASH) proteins revealed by interaction with a muscle-specific
enhancer. Proc. Natl. Acad. Sci. USA 89, 3596–3600.
Jusuf, P.R., and Harris, W.A. (2009). Ptf1a is expressed transiently in all types
of amacrine cells in the embryonic zebrafish retina. Neural Dev. 4, 34.
Kajimura, S., Seale, P., and Spiegelman, B.M. (2010). Transcriptional control of
brown fat development. Cell Metab. 11, 257–262.
Katoh, K., Omori, Y., Onishi, A., Sato, S., Kondo, M., and Furukawa, T. (2010).
Blimp1 suppresses Chx10 expression in differentiating retinal photoreceptor
precursors to ensure proper photoreceptor development. J. Neurosci. 30,
6515–6526.
Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R.J., and
Wright, C.V. (2002). The role of the transcriptional regulator Ptf1a in converting
intestinal to pancreatic progenitors. Nat. Genet. 32, 128–134.
Krapp, A., Kno¨fler, M., Frutiger, S., Hughes, G.J., Hagenbu¨chle, O., and
Wellauer, P.K. (1996). The p48 DNA-binding subunit of transcription factor
PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein.
EMBO J. 15, 4317–4329.
Krapp, A., Kno¨fler, M., Ledermann, B., Bu¨rki, K., Berney, C., Zoerkler, N.,
Hagenbu¨chle, O., and Wellauer, P.K. (1998). The bHLH protein PTF1-p48 is
essential for the formation of the exocrine and the correct spatial organization
of the endocrine pancreas. Genes Dev. 12, 3752–3763.
Lai, H.C., Klisch, T.J., Roberts, R., Zoghbi, H.Y., and Johnson, J.E. (2011).
In vivo neuronal subtype-specific targets of Atoh1 (Math1) in dorsal spinal
cord. J. Neurosci. 31, 10859–10871.
Liu, C., Ma, W., Su, W., and Zhang, J. (2012). Prdm14 acts upstream of islet2
transcription to regulate axon growth of primary motoneurons in zebrafish.
Development 139, 4591–4600.
Liu, Y., and Ma, Q. (2011). Generation of somatic sensory neuron diversity and
implications on sensory coding. Curr. Opin. Neurobiol. 21, 52–60.
Masui, T., Long, Q., Beres, T.M., Magnuson, M.A., and MacDonald, R.J.
(2007). Early pancreatic development requires the vertebrate Suppressor of
Hairless (RBPJ) in the PTF1 bHLH complex. Genes Dev. 21, 2629–2643.
Masui, T., Swift, G.H., Hale, M.A., Meredith, D.M., Johnson, J.E., and
Macdonald, R.J. (2008). Transcriptional autoregulation controls pancreatic
Ptf1a expression during development and adulthood. Mol. Cell. Biol. 28,
5458–5468.
Megason, S.G., and McMahon, A.P. (2002). A mitogen gradient of dorsal
midline Wnts organizes growth in the CNS. Development 129, 2087–2098.DeveMeredith, D.M., Masui, T., Swift, G.H., MacDonald, R.J., and Johnson, J.E.
(2009). Multiple transcriptional mechanisms control Ptf1a levels during neural
development including autoregulation by the PTF1-J complex. J. Neurosci. 29,
11139–11148.
Mizuguchi, R., Kriks, S., Cordes, R., Gossler, A., Ma, Q., and Goulding, M.
(2006). Ascl1 and Gsh1/2 control inhibitory and excitatory cell fate in spinal
sensory interneurons. Nat. Neurosci. 9, 770–778.
Mu¨ller, T., Brohmann, H., Pierani, A., Heppenstall, P.A., Lewin, G.R., Jessell,
T.M., and Birchmeier, C. (2002). The homeodomain factor lbx1 distinguishes
two major programs of neuronal differentiation in the dorsal spinal cord.
Neuron 34, 551–562.
Nakada, Y., Hunsaker, T.L., Henke, R.M., and Johnson, J.E. (2004). Distinct
domains within Mash1 and Math1 are required for function in neuronal differ-
entiation versus neuronal cell-type specification. Development 131, 1319–
1330.
Nakhai, H., Sel, S., Favor, J., Mendoza-Torres, L., Paulsen, F., Duncker, G.I.,
and Schmid, R.M. (2007). Ptf1a is essential for the differentiation of
GABAergic and glycinergic amacrine cells and horizontal cells in the mouse
retina. Development 134, 1151–1160.
Pascual, M., Abasolo, I., Mingorance-Le Meur, A., Martı´nez, A., Del Rio, J.A.,
Wright, C.V., Real, F.X., and Soriano, E. (2007). Cerebellar GABAergic progen-
itors adopt an external granule cell-like phenotype in the absence of Ptf1a
transcription factor expression. Proc. Natl. Acad. Sci. USA 104, 5193–5198.
Rao, M., Baraban, J.H., Rajaii, F., and Sockanathan, S. (2004). In vivo compar-
ative study of RNAi methodologies by in ovo electroporation in the chick
embryo. Dev. Dyn. 231, 592–600.
Ross, S.E. (2011). Pain and itch: insights into the neural circuits of aversive
somatosensation in health and disease. Curr. Opin. Neurobiol. 21, 880–887.
Ross, S.E., McCord, A.E., Jung, C., Atan, D., Mok, S.I., Hemberg, M., Kim,
T.K., Salogiannis, J., Hu, L., Cohen, S., et al. (2012). Bhlhb5 and Prdm8 form
a repressor complex involved in neuronal circuit assembly. Neuron 73,
292–303.
Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scime`, A.,
Devarakonda, S., Conroe, H.M., Erdjument-Bromage, H., et al. (2008).
PRDM16 controls a brown fat/skeletal muscle switch. Nature 454, 961–967.
Smith, S.T., and Jaynes, J.B. (1996). A conserved region of engrailed, shared
among all en-, gsc-, Nk1-, Nk2- and msh-class homeoproteins, mediates
active transcriptional repression in vivo. Development 122, 3141–3150.
Tavares, I., and Lima, D. (2007). From neuroanatomy to gene therapy: search-
ing for new ways to manipulate the supraspinal endogenous pain modulatory
system. J. Anat. 211, 261–268.
Timmer, J., Johnson, J., and Niswander, L. (2001). The use of in ovo electro-
poration for the rapid analysis of neural-specific murine enhancers. Genesis
29, 123–132.
Triezenberg, S.J., Kingsbury, R.C., and McKnight, S.L. (1988). Functional
dissection of VP16, the trans-activator of herpes simplex virus immediate early
gene expression. Genes Dev. 2, 718–729.
Wildner, H., Mu¨ller, T., Cho, S.H., Bro¨hl, D., Cepko, C.L., Guillemot, F., and
Birchmeier, C. (2006). dILA neurons in the dorsal spinal cord are the product
of terminal and non-terminal asymmetric progenitor cell divisions, and require
Mash1 for their development. Development 133, 2105–2113.
Yamamoto, N., Yamamoto, S., Inagaki, F., Kawaichi, M., Fukamizu, A., Kishi,
N., Matsuno, K., Nakamura, K., Weinmaster, G., Okano, H., and Nakafuku, M.
(2001). Role of Deltex-1 as a transcriptional regulator downstream of the Notch
receptor. J. Biol. Chem. 276, 45031–45040.
Yang, N., Ng, Y.H., Pang, Z.P., Su¨dhof, T.C., and Wernig, M. (2011). Induced
neuronal cells: how to make and define a neuron. Cell Stem Cell 9, 517–525.
Zeng, P.Y., Vakoc, C.R., Chen, Z.C., Blobel, G.A., and Berger, S.L. (2006).
In vivo dual cross-linking for identification of indirect DNA-associated proteins
by chromatin immunoprecipitation. Biotechniques 41, 694, 696, 698.
Zhuang, B., and Sockanathan, S. (2006). Dorsal-ventral patterning: a view from
the top. Curr. Opin. Neurobiol. 16, 20–24.lopmental Cell 25, 182–195, April 29, 2013 ª2013 Elsevier Inc. 195
